Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Lenvatinib in Combination With Pembrolizumab in HPV-associated Recurrent Respiratory Papillomatosis Patients

NCT04645602 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04645602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04645602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Lenvatinib in Combination With Pembrolizumab in HPV-associated Recurrent Respiratory Papillomatosis Patients
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
July 18, 2025
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus, pulmonary disease, recurrent respiratory papillomatosis